Skip to content

Improving quality of care for patients with recurrent ovarian cancer

Improving quality of care for patients with recurrent ovarian cancer - MOGYN21 QoC Ovarium Carcinoma

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON45807
Enrollment
300
Registered
2016-05-09
Start date
2016-05-01
Completion date
Unknown
Last updated
2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cancer of the ovary Ovarian cancer

Interventions

None listed

Sponsors

Radboud Universitair Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: • Patients with recurrent EOC or tubal carcinoma or peritoneal carcinoma; • Histologically and/or cytologically proven epithelial ovarian cancer (including carcinosarcoma of the ovaries) • Measurable or evaluable disease confirmed by radiological imaging OR ca 125 • ECOG =12 weeks • Patients must be accessible for treatment and follow-up • Fit to receive chemotherapy

Exclusion criteria

Exclusion criteria: • Patients with benign ovarian cancer; • Patients with non-epithelial cancer; • Bowel obstruction, sub-occlusive disease or presence of symptomatic brain metastases; • Patients with other malignancy occurring within 5 years before enrollment • Patients with impaired cognitive functioning or analphabetic patients • Patients with an inability to fill in surveys digitally

Design outcomes

Primary

MeasureTime frame
the velocity of disease symptom relief and its duration by systemic therapy measured by questionnaires on PROs and response to therapy. Primary endpoints: changes in outcomes on QoL and symptoms due to disease and treatment.

Secondary

MeasureTime frame
Petient reported disease symptoms top 3, response to therapy as measured by CA-125 and radiology, distress, emotional wellbeing, Empowerment and change in patient reported needs.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)